SOS1 - SOS Ras/Rac guanine nucleotide exchange factor 1 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100520187
SOS1 Products (5)
| mRNA | Protein | Name |
|---|---|---|
| XM_021087586.1 | XP_020943245.1 | son of sevenless homolog 1 isoform X1 |
| XM_021087587.1 | XP_020943246.1 | son of sevenless homolog 1 isoform X2 |
| XM_021087589.1 | XP_020943248.1 | son of sevenless homolog 1 isoform X4 |
| XM_021087590.1 | XP_020943249.1 | son of sevenless homolog 1 isoform X5 |
| XM_021087588.1 | XP_020943247.1 | son of sevenless homolog 1 isoform X3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
son of sevenless homolog 1 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Pre-clinical Phase
Bioactive Molecules
(92)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-125817 | BI-3406 | Inhibitor | 99.95% | Unkown |
| HY-114398 | BAY-293 | Inhibitor | 98.97% | Unkown |
| HY-134885 | RMC-0331 | Inhibitor | 98.96% | Unkown |
| HY-111671 | VUBI1 | 98.21% | Unkown | |
| HY-161233A | BTX-6654 formate | 98.85% | Unkown | |
| HY-153606 | VUBI1 analogue-1 | 98.94% | Unkown | |
| HY-P2265A | SAH-SOS1A TFA | Inhibitor | 96.55% | Unkown |
| HY-W056267 | 3-Boc-3-azaspiro[5.5]undecane-9-carbaldehyde | 98.0% | Unkown | |
| HY-151517 | SOS1-IN-14 | Inhibitor | 99.60% | Unkown |
| HY-161235 | BTX-7312 | 98.35% | Unkown | |
| HY-163939 | RGT-018 | Inhibitor | 99.77% | Unkown |
| HY-144962 | SOS1-IN-11 | Inhibitor | 98.22% | Unkown |
| HY-145737A | PROTAC SOS1 degrader-1 TFA | 98.38% | Unkown | |
| HY-W115490 | 4-Chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)benzoic acid | 98.28% | Unkown | |
| HY-151881 | SOS1-IN-15 | Inhibitor | 98.04% | Unkown |
| HY-134813A | MRTX1133 formic | Inhibitor | 98.23% | Unkown |
| HY-101796 | NSC-70220 | Inhibitor | 99.42% | Unkown |
| HY-161233 | BTX-6654 | / | Unkown | |
| HY-114398A | (S)-BAY-293 | 97.8% | Unkown | |
| HY-144657A | (4S)-PROTAC SOS1 degrader-1 diTFA | Inhibitor | 98.09% | Unkown |
| HY-148278 | BI-0474 | Inhibitor | 99.83% | Unkown |
| HY-158310 | SOS1/EGFR-IN-1 | Inhibitor | 99.54% | Unkown |
| HY-RS13576 | SOS1 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-144212 | SOS1-IN-8 | Inhibitor | / | Unkown |
| HY-122685 | UC-773587 | Inhibitor | / | Unkown |
| HY-124514 | UC-857993 | Inhibitor | / | Unkown |
| HY-124755 | RAS activator compound 1 | Activator | 98.90% | Unkown |
| HY-132129 | SOS1-IN-2 | Inhibitor | / | Unkown |
| HY-144207 | SOS1-IN-9 | Inhibitor | / | Unkown |
| HY-144210 | SOS1-IN-6 | Inhibitor | / | Unkown |
| HY-144211 | SOS1-IN-7 | Inhibitor | / | Unkown |
| HY-144213 | SOS1-IN-10 | Inhibitor | / | Unkown |
| HY-144657 | (4S)-PROTAC SOS1 degrader-1 | / | Unkown | |
| HY-144965 | SOS1-IN-12 | Inhibitor | / | Unkown |
| HY-144967 | SOS1-IN-13 | Inhibitor | / | Unkown |
| HY-145046 | SOS1-IN-3 | Inhibitor | / | Unkown |
| HY-145047 | SOS1-IN-4 | Inhibitor | / | Unkown |
| HY-145048 | SOS1-IN-5 | Inhibitor | / | Unkown |
| HY-145737 | PROTAC SOS1 degrader-1 | / | Unkown | |
| HY-148261 | KRAS G12C inhibitor 56 | Inhibitor | / | Unkown |
| HY-151968 | KRAS G12C inhibitor 57 | Inhibitor | / | Unkown |
| HY-152145 | PROTAC SOS1 degrader-3 | / | Unkown | |
| HY-153674 | PROTAC SOS1 degrader-4 | / | Unkown | |
| HY-153940 | SOS1/KRAS-IN-1 | Inhibitor | / | Unkown |
| HY-153989 | SOS1-IN-16 | Inhibitor | / | Unkown |
| HY-161173 | PROTAC SOS1 degrader-5 | / | Unkown | |
| HY-161236 | KRAS ligand 4 | Inhibitor | / | Unkown |
| HY-161450 | LHF418 | Inhibitor | / | Unkown |
| HY-161452 | SOS1 Ligand intermediate-3 | Inhibitor | / | Unkown |
| HY-161634 | PROTAC SOS1 degrader-8 | / | Unkown | |
| HY-161635 | SOS1 Ligand intermediate-4 | Inhibitor | / | Unkown |
| HY-161636 | PROTAC SOS1 degrader-9 | / | Unkown | |
| HY-161637 | E3 ligase Ligand 25 | / | Unkown | |
| HY-161639 | E3 ligase Ligand 26 | / | Unkown | |
| HY-161654 | PROTAC SOS1 degrader-10 | / | Unkown | |
| HY-161714 | HH0043 | Inhibitor | / | Unkown |
| HY-162281 | PROTAC SOS1 degrader-6 | / | Unkown | |
| HY-163582 | PROTAC SOS1 degrader-7 | / | Unkown | |
| HY-167768 | SOS1 activator 2 | / | Unkown | |
| HY-168514 | SOS1/EGFR-IN-2 | Inhibitor | / | Unkown |
| HY-168637 | SIAIS562055 | / | Unkown | |
| HY-168638 | PROTAC SOS1 ligand 1 | Inhibitor | / | Unkown |
| HY-168716 | SOS1-IN-17 | Inhibitor | / | Unkown |
| HY-169371 | SOS1 Ligand intermediate-7 | Inhibitor | / | Unkown |
| HY-172221 | SOS1-IN-18 | Inhibitor | / | Unkown |
| HY-173047 | KRASG12C IN-15 | Inhibitor | / | Unkown |
| HY-173341 | SOF-436 | Inhibitor | / | Unkown |
| HY-175244 | SOS1-IN-20 | Inhibitor | / | Unkown |
| HY-175326 | SOS1-IN-21 | Inhibitor | / | Unkown |
| HY-175560 | SOS1-IN-22 | Inhibitor | / | Unkown |
| HY-175575 | SOS1 ligand-2 | Ligand | / | Unkown |
| HY-175891 | POI ligand-5 | / | Unkown | |
| HY-176170 | SOS1-IN-19 | Inhibitor | / | Unkown |
| HY-176789 | VUBI1-octanoic acid | Inhibitor | / | Unkown |
| HY-178044 | SOS1-IN-24 | Inhibitor | / | Unkown |
| HY-179414 | KRAS G12D-IN-34 | Inhibitor | / | Unkown |
| HY-179443 | SOS1-IN-25 | Inhibitor | / | Unkown |
| HY-181807 | SOS1/KRAS-IN-2 | / | Unkown | |
| HY-182411 | KRAS-IN-56 | Inhibitor | / | Unkown |
| HY-183365 | SL43 | Inhibitor | / | Unkown |
| HY-19539 | NSC-658497 | Inhibitor | / | Unkown |
| HY-P2265 | SAH-SOS1A | Inhibitor | / | Unkown |
| HY-112078B | (S,S,S)-AHPC-Me | / | Unkown | |
| HY-161638 | E3 Ligase Ligand-linker Conjugate 108 | / | Unkown | |
| HY-161640 | E3 Ligase Ligand-linker Conjugate 109 | / | Unkown | |
| HY-161655 | SOS1 Ligand intermediate-5 | Inhibitor | / | Unkown |
| HY-161656 | PIP-C-3-Azaspiro[5.5]undecane-boc | / | Unkown | |
| HY-161657 | 2-Methoxyphenyl dihydrouracil-azaspiro[5.5]undecane-C-PIP | / | Unkown | |
| HY-163583 | SOS1 Ligand intermediate-6 | Inhibitor | / | Unkown |
| HY-RS16568 | Sos1 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS23001 | Sos1 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-RS26460 | Sos2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |